We are live on ! Find out more
MTNB icon

Matinas BioPharma
MTNB

80 hedge funds and large institutions have $41.7M invested in Matinas BioPharma in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 12

57% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 14

13% more funds holding

Funds holding: 71 → 80 (+9)

0.02% less ownership

Funds ownership: 0.42% → 0.4% (-0.02%)

27% less capital invested

Capital invested by funds: $57.1M → $41.7M (-$15.3M)

Holders
80
Holders Change
+9
Holders Change %
+12.68%
% of All Funds
1.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
22
Reduced
14
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
+$4.81M
2
BlackRock
BlackRock
New York
+$1.25M
3
HF
HRT Financial
New York
+$998K
4
SIG
Sargent Investment Group
Maryland
+$777K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$407K

Top Sellers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
-$8.77M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.45M
3
PFMOSF
Philadelphia Financial Management of San Francisco
California
-$1.01M
4
CIBC Private Wealth Group
CIBC Private Wealth Group
Georgia
-$816K
5
Millennium Management
Millennium Management
New York
-$549K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Boxer Capital
California
$12.1M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$8.24M +$206K +3,064 +2%
AFM
3
Anson Funds Management
Texas
$3.76M +$4.81M +71,680 New
BlackRock
4
BlackRock
New York
$3.33M +$1.25M +18,629 +42%
SIG
5
Sargent Investment Group
Maryland
$2.11M +$777K +11,589 +41%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$1.33M +$194K +2,891 +13%
Victory Capital Management
7
Victory Capital Management
Texas
$1.03M -$57K -850 -4%
Royal Bank of Canada
8
Royal Bank of Canada
Ontario, Canada
$821K -$39.5K -589 -4%
HF
9
HRT Financial
New York
$780K +$998K +14,874 New
BCM
10
Bridgeway Capital Management
Texas
$712K -$528K -7,874 -37%
SCA
11
STALEY CAPITAL ADVISERS
Pennsylvania
$630K – – –
Two Sigma Advisers
12
Two Sigma Advisers
New York
$554K -$71K -1,058 -9%
MSFS
13
Main Street Financial Solutions
Pennsylvania
$421K – – –
DA
14
DCF Advisers
Connecticut
$420K +$127K +1,894 +31%
Squarepoint
15
Squarepoint
New York
$407K +$302K +4,500 +138%
ECM
16
ExodusPoint Capital Management
New York
$400K -$332K -4,946 -39%
California Public Employees Retirement System
17
California Public Employees Retirement System
California
$370K – – –
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$347K +$407K +6,065 +1,123%
Northern Trust
19
Northern Trust
Illinois
$338K +$62.6K +933 +17%
Citadel Advisors
20
Citadel Advisors
Florida
$330K +$279K +4,155 +194%
SWM
21
Spire Wealth Management
Virginia
$292K +$353K +5,263 New
Truist Financial
22
Truist Financial
North Carolina
$215K +$275K +4,102 New
Bank of New York Mellon
23
Bank of New York Mellon
New York
$193K -$21.6K -322 -8%
AC
24
AWH Capital
Texas
$184K +$235K +3,500 New
T. Rowe Price Associates
25
T. Rowe Price Associates
Maryland
$178K +$228K +3,396 New
1
2 3 4

MTNB Hedge Fund Activity: Q1 2021 in Review

80 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Matinas BioPharma (MTNB) for Q1 2021, worth a combined $41.7M — down 27% from $57.1M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new MTNB positions and 12 closed out — a net gain of 10 holders — while 22 added to existing stakes and 14 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $4.81M. The largest seller was Vivo Capital, exiting entirely with an estimated $8.77M sold.

  • 80 institutional investors held Matinas BioPharma (MTNB) as of Q1 2021, up from 71 in Q4 2020.
  • Funds reported $41.7M of Matinas BioPharma stock for Q1 2021, down 27% quarter-over-quarter.
  • 22 funds opened new Matinas BioPharma positions in Q1 2021 and 12 closed out, a net change of +10 holders.
  • The largest Matinas BioPharma buyer in Q1 2021 was Anson Funds Management, an estimated $4.81M added.
  • The largest Matinas BioPharma seller in Q1 2021 was Vivo Capital, an estimated $8.77M sold.

Based on aggregated 13F filings for Q1 2021.